JARID2 and rhabdomyosarcoma: Abnormal JARID2 expression had been reported in rhabdomyosarcomas and leukemia, [15, 16] and contributed to metastatic behavior of cancer cells by promoting epithelial-mesenchymal transition (EMT) [17].